Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Melissa M. Tomkiel is President and General Counsel at Strata Critical Medical. OQRO lists 9 transactions filed with the SEC under this name, the latest on Sep 25, 2026, each linked to the official Form 4.
President and General Counsel
Disclosures on record
9
Companies involved
1
Strata Critical MedicalSRTA
9 disclosures · Nov 2024 – Sep 2026 · 7 sold
Sep 24, 2026178Kdisclosed Sep 25
DetailsOfficial recordSep 24, 202691Kdisclosed Sep 25
DetailsOfficial recordAug 4, 2025Sold~$237Kdisclosed Aug 5
DetailsOfficial recordJun 9, 2025Sold~$408Kdisclosed Jun 11
DetailsOfficial recordDec 9, 2024Sold~$113Kdisclosed Dec 11
DetailsOfficial recordNov 27, 2024Sold~$201Kdisclosed Nov 29
DetailsOfficial recordNov 27, 2024Sold~$190Kdisclosed Nov 29
DetailsOfficial recordNov 29, 2024Sold~$111K
DetailsOfficial recordNov 12, 2024Sold~$152Kdisclosed Nov 13
DetailsOfficial recordAs of the latest filing on , Melissa M. Tomkiel reported holding 2,153,678 shares of Strata Critical Medical (SRTA), worth about $11.9M at the last close of $6 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Strata Critical Medical SRTA | 2,153,678 | 2.15M direct | $6 | $11.9M | Sep 24, 2026 |
Is this Melissa M. Tomkiel’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Melissa M. Tomkiel has no open-market purchase on record since 2022. Sales in each of the last 4 years.
Melissa M. Tomkiel reported 0 open-market purchases and 25 sales since 2022; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $645K2×2 trades |
| 2024 | — | $1.02M9×9 trades |
| 2023 | — | $685K13×13 trades |
| 2022 | — | $17K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Sep 24, 2026, Melissa M. Tomkiel reported holding 2,153,678 shares of Strata Critical Medical (SRTA). At the last close of $6 on Nov 13, 2026, that is about $11.9M. This is the stake disclosed in filings, not a net worth.
Melissa M. Tomkiel has no open-market purchase on record since 2022. Sales in each of the last 4 years.
In SEC filings since 2022: no open-market purchase is on record; the latest open-market sale is from 2025.
Strata Critical Medical (SRTA), from 2022 to 2025: 0 purchases and 25 sales.
Melissa M. Tomkiel reported 0 open-market purchases and 25 sales here, 2022 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
